Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis

2025Current Pulmonology ReportsJournal

10.1007/s13665-025-00389-w Full text1 citations

Authors

11 authors across 5 institutions in 3 countries.

Patrick AshinzeFirst authorCorresponding
- University of Ilorin (NG)
Abdullaah Idris Agbabiaka
Eniola Akande
- University of Ilorin (NG)
Aremu Sikiru
- University of Ilorin (NG)
Onosegbe Moses Aikhuomogbe
Elelu Taiye Muhammed
- University of Ilorin (NG)
Eniola Obafemi
- University of Ilorin (NG)
Akogwu Edache Ocholi
- University of Ilorin (NG)
Emmanuel O. Egbunu
- Federal Medical Centre (NG)
as printed: Egbunu Emmanuel
Nelson Mafua
- Madonna University (NG)
Suvam BanerjeeSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Cystic Fibrosis Research Advanceslevel 3 · 1.00
Nematode management and characterization studieslevel 3 · 0.95

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · Current Pulmonology Reports · 1 citations
https://openalex.org/W4414000819

Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis · Sankore